{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:56:02Z","timestamp":1783958162669,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15HL138606-01A1"],"award-info":[{"award-number":["1R15HL138606-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioadv.2024.214027","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:03:23Z","timestamp":1725379403000},"page":"214027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections \u2013 Development and in-vitro characterization"],"prefix":"10.1016","volume":"166","author":[{"given":"Gautam","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul A.","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti S.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimpy","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Mokashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimansa","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh K.","family":"Kunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2024.214027_bb0005","doi-asserted-by":"crossref","unstructured":"Warnock L, Gates A. Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis. Cochrane Database Syst. Rev. [Internet]. 2023;(4). [cited 2023 Oct 1], Available from: https:\/\/doi.org\/10.1002\/14651858.CD001401.pub4\/full.","DOI":"10.1002\/14651858.CD001401.pub4"},{"issue":"6","key":"10.1016\/j.bioadv.2024.214027_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0039-1694021","article-title":"Cystic fibrosis: pathophysiology of lung disease","volume":"40","author":"Bergeron","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.bioadv.2024.214027_bb0015","unstructured":"chapter-7-cystic-fibrosis.pdf [Internet]. [cited 2019 Oct 14]. Available from: https:\/\/www.thoracic.org\/patients\/patient-resources\/breathing-in-america\/resources\/chapter-7-cystic-fibrosis.pdf."},{"issue":"9","key":"10.1016\/j.bioadv.2024.214027_bb0020","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/ppul.26527","article-title":"Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: healthcare providers\u2019 observations across US centers","volume":"58","author":"Bathgate","year":"2023","journal-title":"Pediatr. Pulmonol."},{"issue":"7","key":"10.1016\/j.bioadv.2024.214027_bb0025","first-page":"500","article-title":"CFTR modulators for the treatment of cystic fibrosis","volume":"39","author":"Pettit","year":"2014","journal-title":"Pharm. Ther."},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.mpmed.2016.02.016","article-title":"Cystic fibrosis","volume":"44","author":"Antoniou","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bioadv.2024.214027_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.msec.2018.10.064","article-title":"Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier","volume":"95","author":"Cristallini","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.bioadv.2024.214027_bb0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/cid\/ciy215","article-title":"Changing rates of chronic Pseudomonas aeruginosa infections in cystic fibrosis: a population-based cohort study","volume":"67","author":"Crull","year":"2018","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2024.214027_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2015.12.028","article-title":"Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis","volume":"498","author":"Moreno-Sastre","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0050","first-page":"338","article-title":"Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives","volume":"10","author":"Taccetti","year":"2021","journal-title":"Antibiot. Basel Switz."},{"issue":"10","key":"10.1016\/j.bioadv.2024.214027_bb0055","article-title":"Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis","volume":"2018","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0060","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis","volume":"2018","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.bioadv.2024.214027_bb0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jcf.2017.02.006","article-title":"A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis","volume":"16","author":"Plant","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2014.10.011","article-title":"Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins","volume":"135","author":"Gaeta","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bioadv.2024.214027_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2016.01.025","article-title":"Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell\u2013mediated hypersensitivity to penicillins","volume":"138","author":"Romano","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0080","unstructured":"MedchemExpress.com [Internet]. [cited 2024 Feb 14]. Aztreonam (SQ-26,776) | Bacterial Inhibitor | MedChemExpress. Available from: https:\/\/www.medchemexpress.com\/Aztreonam.html."},{"key":"10.1016\/j.bioadv.2024.214027_bb0085","unstructured":"Aztreonam Injection: MedlinePlus Drug Information [Internet]. [cited 2023 Oct 3]. Available from: https:\/\/medlineplus.gov\/druginfo\/meds\/a687010.html."},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0090","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/pharmaceutics15051488","article-title":"Dry powder inhalation for lung delivery in cystic fibrosis","volume":"15","author":"Han","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2024.214027_bb0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd3170","article-title":"Inhaled aztreonam","volume":"9","author":"O\u2019Sullivan","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2024.214027_bb0100","series-title":"Cost comparison table for drugs used for cystic fibrosis [Internet]","author":"Information NC for B","year":"2015"},{"key":"10.1016\/j.bioadv.2024.214027_bb0105","unstructured":"Taking Cayston | CAYSTON\u00ae (aztreonam for inhalation solution) [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www.cayston.com\/taking-cayston."},{"key":"10.1016\/j.bioadv.2024.214027_bb0110","unstructured":"Recent advances in materials for extended-release antibiotic delivery system | The Journal of Antibiotics [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www.nature.com\/articles\/ja201158."},{"key":"10.1016\/j.bioadv.2024.214027_bb0115","unstructured":"ARIKAYCE\u00ae (amikacin liposome inhalation suspension) - Insmed [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/insmed.com\/science\/our-pillars\/arikayce\/."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcf.2011.02.007","article-title":"Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa","volume":"10","author":"Wainwright","year":"2011","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"10.1016\/j.bioadv.2024.214027_bb0125","author":"Montgomery"},{"issue":"6","key":"10.1016\/j.bioadv.2024.214027_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajps.2015.08.002","article-title":"The influence of amino acids on aztreonam spray-dried powders for inhalation","volume":"10","author":"Yang","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2024.214027_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40273-013-0122-x","article-title":"The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis","volume":"32","author":"Tappenden","year":"2014","journal-title":"PharmacoEconomics"},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/2211738511666230223141759","article-title":"In vitro\/in vivo evaluation of elastic nano-lipid carriers of Aztreonam for pneumonic lungs","volume":"11","author":"Bhattacharyya","year":"2023","journal-title":"Pharm. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.34172\/apb.2021.074","article-title":"Experimental design supported liposomal Aztreonam delivery: in vitro studies","volume":"11","author":"Bhattacharyya","year":"2021","journal-title":"Adv. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0150","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s13346-018-0550-4","article-title":"Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations","volume":"8","author":"Ngan","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"9","key":"10.1016\/j.bioadv.2024.214027_bb0155","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/biomedicines10092179","article-title":"Lipid nanoparticles as delivery vehicles for inhaled therapeutics","volume":"10","author":"Leong","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/pharmaceutics15030996","article-title":"Scalable production and in vitro efficacy of inhaled erlotinib nanoemulsion for enhanced efficacy in non-small cell lung cancer (NSCLC)","volume":"15","author":"Chauhan","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2024.214027_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2024.214027_bb0170","unstructured":"Chauhan G, Shaik AA, Kulkarni NS, Gupta V. The preparation of lipid-based drug delivery system using melt extrusion. Drug Discov. Today [Internet]. 2020 Aug 21 [cited 2020 Oct 20]; Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1359644620303305."},{"issue":"9","key":"10.1016\/j.bioadv.2024.214027_bb0175","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2013.814065","article-title":"Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation","volume":"40","author":"Nesamony","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"8","key":"10.1016\/j.bioadv.2024.214027_bb0180","first-page":"585","article-title":"Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery","volume":"65","author":"Hu","year":"2010","journal-title":"Pharm"},{"key":"10.1016\/j.bioadv.2024.214027_bb0185","first-page":"151","article-title":"Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization","volume":"125","author":"Nafee","year":"2018","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2024.214027_bb0190","doi-asserted-by":"crossref","unstructured":"Nielsen CK, Kjems J, Mygind T, Snabe T, Meyer RL. Effects of tween 80 on growth and biofilm formation in laboratory media. Front. Microbiol. [Internet]. 2016 Nov 22 ;7. [cited 2019 Oct 10], Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5118432\/.","DOI":"10.3389\/fmicb.2016.01878"},{"issue":"50","key":"10.1016\/j.bioadv.2024.214027_bb0195","doi-asserted-by":"crossref","first-page":"15714","DOI":"10.1021\/acs.langmuir.2c02520","article-title":"Interactions of surfactants with the bacterial cell wall and inner membrane: revealing the link between aggregation and antimicrobial activity","volume":"38","author":"Sharma","year":"2022","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0200","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jsde.12293","article-title":"Surfactants as antimicrobials: a brief overview of microbial interfacial chemistry and surfactant antimicrobial activity","volume":"22","author":"Falk","year":"2019","journal-title":"J. Surfactant Deterg."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0205","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1166\/jnn.2012.6148","article-title":"Antibacterial activities of polyethylene glycol, tween 80 and sodium dodecyl sulphate coated silver nanoparticles in normal and multi-drug resistant bacteria","volume":"12","author":"Bhattacharya","year":"2012","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1461-5347(00)00247-9","article-title":"Recent technological advances in oral drug delivery \u2013 a review","volume":"3","author":"Sastry","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"2","key":"10.1016\/j.bioadv.2024.214027_bb0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1472-765X.2003.01266.x","article-title":"Microemulsions are highly effective anti-biofilm agents","volume":"36","author":"Al-Adham","year":"2003","journal-title":"Lett. Appl. Microbiol."},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0220","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/AAC.00196-16","article-title":"Sequential treatment of biofilms with aztreonam and tobramycin is a novel strategy for combating Pseudomonas aeruginosa chronic respiratory infections","volume":"60","author":"Rojo-Molinero","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioadv.2024.214027_bb0225","unstructured":"Developments and Challenges: Adapting Continuous Manufacturing for Pharmaceuticals - AAPS News Magazine [Internet]. [cited 2019 Oct 3]. Available from: https:\/\/www.aapsnewsmagazine.org\/articles\/2019\/apr19\/cover-story-apr19."},{"issue":"1","key":"10.1016\/j.bioadv.2024.214027_bb0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1208\/s12248-014-9674-8","article-title":"Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach","volume":"17","author":"Patil","year":"2014","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0235","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.xphs.2016.12.015","article-title":"A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology","volume":"106","author":"Bhagurkar","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2024.214027_bb0240","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.powtec.2016.06.032","article-title":"A physically stabilized amorphous solid dispersion of nisoldipine obtained by hot melt extrusion","volume":"301","author":"Fu","year":"2016","journal-title":"Powder Technol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejps.2018.02.019","article-title":"Impact of change of matrix crystallinity and polymorphism on ovalbumin release from lipid-based implants","volume":"117","author":"Duque","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2024.214027_bb0250","article-title":"New lipid-based formulation approaches\/tools in hot-melt extrusion [internet]","author":"Philippe","year":"2017","journal-title":"Pharma Excipients"},{"key":"10.1016\/j.bioadv.2024.214027_bb0255","article-title":"Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology","volume":"3","author":"Shadambikar","year":"2021","journal-title":"Int. J. Pharm. X."},{"key":"10.1016\/j.bioadv.2024.214027_bb0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijbiomac.2020.07.124","article-title":"Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer","volume":"164","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.bioadv.2024.214027_bb0265","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s11095-022-03392-x","article-title":"Inhaled indomethacin-loaded liposomes as potential therapeutics against non-small cell lung cancer (NSCLC)","volume":"39","author":"Sarvepalli","year":"2022","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.bioadv.2024.214027_bb0270","article-title":"Acidic microenvironment determines antibiotic susceptibility and biofilm formation of Pseudomonas aeruginosa","author":"Lin","year":"2021","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.114866","article-title":"Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation \u2013 evaluation of intestinal absorption and anti-cancer activity","volume":"327","author":"Parvathaneni","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioadv.2024.214027_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.carbpol.2018.03.101","article-title":"Eugenol-chitosan nanoemulsions by ultrasound-mediated emulsification: formulation, characterization and antimicrobial activity","volume":"193","author":"Shao","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2024.214027_bb0290","article-title":"Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment","volume":"87","author":"Goyal","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0295","doi-asserted-by":"crossref","unstructured":"Wang Q, Zhang H, Han Y, Cui Y, Han X. Study on the relationships between the oil HLB value and emulsion stabilization. RSC Adv. 13(35):24692\u20138.","DOI":"10.1039\/D3RA04592G"},{"key":"10.1016\/j.bioadv.2024.214027_bb0300","unstructured":"Gattefoss\u00e9 [Internet]. [cited 2024 Jul 21]. Labrafac\u2122 Lipophile WL 1349 \u00b7 Gattefoss\u00e9. Available from: https:\/\/www.gattefosse.com\/pharmaceuticals\/product-finder\/labrafac-lipophile-wl-1349."},{"key":"10.1016\/j.bioadv.2024.214027_bb0305","unstructured":"Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies - PMC [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www-ncbi-nlm-nih-gov.jerome.stjohns.edu\/pmc\/articles\/PMC9726673\/."},{"key":"10.1016\/j.bioadv.2024.214027_bb0310","unstructured":"Labrafil\u00ae M 1944 CS \u00b7 Gattefoss\u00e9 [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www.gattefosse.com\/pharmaceuticals\/product-finder\/labrafil-m-1944-cs."},{"key":"10.1016\/j.bioadv.2024.214027_bb0315","unstructured":"Gattefoss\u00e9 [Internet]. [cited 2024 Jul 21]. Labrafil\u00ae M 2125 CS \u00b7 Gattefoss\u00e9. Available from: https:\/\/www.gattefosse.com\/pharmaceuticals\/product-finder\/labrafil-m-2125-cs."},{"issue":"2","key":"10.1016\/j.bioadv.2024.214027_bb0320","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1208\/s12249-015-0370-5","article-title":"Development of solid self-emulsifying formulation for improving the oral bioavailability of Erlotinib","volume":"17","author":"Truong","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.bioadv.2024.214027_bb0325","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11095-008-9641-0","article-title":"Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis","volume":"25","author":"Larsen","year":"2008","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2024.214027_bb0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1208\/s12249-010-9385-0","article-title":"Preparation and bioavailability assessment of SMEDDS containing valsartan","volume":"11","author":"Dixit","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2024.214027_bb0335","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.colsurfa.2016.09.074","article-title":"Assessing the stability of tween 80-based O\/W emulsions with cyclic voltammetry and electrical impedance spectroscopy","volume":"511","author":"Roldan-Cruz","year":"2016","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioadv.2024.214027_bb0340","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jconrel.2022.02.007","article-title":"The effects of glycols on molecular mobility, structure, and permeability in stratum corneum","volume":"343","author":"Kis","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2024.214027_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105035","article-title":"CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect","volume":"235","author":"Ashhar","year":"2021","journal-title":"Chem. Phys. Lipids"},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0350","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10837450600767342","article-title":"The importance of the cosolvent propylene glycol on the antimicrobial preservative efficacy of a pharmaceutical formulation by DOE-ruggedness testing","volume":"11","author":"De Spiegeleer","year":"2006","journal-title":"Pharm. Dev. Technol."},{"issue":"8","key":"10.1016\/j.bioadv.2024.214027_bb0355","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jps.2600790803","article-title":"Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity","volume":"79","author":"Kronberg","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2024.214027_bb0360","unstructured":"Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose - ScienceDirect [Internet]. [cited 2024 Feb 10]. Available from: https:\/\/www-sciencedirect-com.jerome.stjohns.edu\/science\/article\/pii\/S0378517321002325."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2024.214027_bb0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2011.04.017","article-title":"Influence of PEI as a core modifying agent on PLGA microspheres of PGE\u2081, a pulmonary selective vasodilator","volume":"413","author":"Gupta","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0370","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1566523023347832","article-title":"Non-viral approach toward gene therapy of cystic fibrosis lung disease","volume":"2","author":"Bragonzi","year":"2002","journal-title":"Curr. Gene Ther."},{"issue":"10","key":"10.1016\/j.bioadv.2024.214027_bb0375","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/polym11101570","article-title":"Emulsion formation and stabilization by biomolecules: the leading role of cellulose","volume":"11","author":"Costa","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.bioadv.2024.214027_bb0380","doi-asserted-by":"crossref","unstructured":"Salawi A. Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv. 29(1):1811\u201323.","DOI":"10.1080\/10717544.2022.2083724"},{"key":"10.1016\/j.bioadv.2024.214027_bb0385","unstructured":"Controlling the morphology of poly(ethyleneimine)\/gold nanoassemblies through the variation of pH and electrolyte additives - ScienceDirect [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0167732220342215."},{"issue":"7","key":"10.1016\/j.bioadv.2024.214027_bb0390","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7150\/jca.13855","article-title":"Role of four different kinds of Polyethylenimines (PEIs) in preparation of polymeric lipid nanoparticles and their anticancer activity study","volume":"7","author":"Yu","year":"2016","journal-title":"J. Cancer"},{"issue":"115","key":"10.1016\/j.bioadv.2024.214027_bb0395","article-title":"Development of pharmaceutically scalable inhaled anti-cancer nanotherapy \u2013 repurposing amodiaquine for non-small cell lung cancer (NSCLC)","author":"Parvathaneni","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0400","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/apj.144","article-title":"The forces at work in colloidal self-assembly: a review on fundamental interactions between colloidal particles","author":"Li","year":"2008","journal-title":"Asia-Pacific J. Chem. Eng."},{"key":"10.1016\/j.bioadv.2024.214027_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132526","article-title":"Chitosan\/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs","volume":"271","author":"Chauhan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0410","unstructured":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics | Experimental & Molecular Medicine [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/www.nature.com\/articles\/s12276-023-01086-x."},{"key":"10.1016\/j.bioadv.2024.214027_bb0415","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2024.214027_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123095","article-title":"Competition between hydrogen bonding and electrostatic repulsion in pH-switchable emulsions","volume":"390","author":"Lv","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioadv.2024.214027_bb0425","unstructured":"78110-38-0 CAS MSDS (Aztreonam) Melting Point Boiling Point Density CAS Chemical Properties [Internet]. [cited 2020 Oct 12]. Available from: https:\/\/www.chemicalbook.com\/ChemicalProductProperty_US_CB0386184.aspx."},{"key":"10.1016\/j.bioadv.2024.214027_bb0430","series-title":"Analytical Profiles of Drug Substances","author":"Florey","year":"1972"},{"key":"10.1016\/j.bioadv.2024.214027_bb0435","article-title":"Development of sustained release lipid-based matrix microparticles for vaginal delivery using twin-screw hot melt extrusion [internet]","author":"philippe","year":"2020","journal-title":"Pharma Excipients"},{"issue":"6","key":"10.1016\/j.bioadv.2024.214027_bb0440","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.3390\/ijms24065204","article-title":"Surface-modified inhaled microparticle-encapsulated celastrol for enhanced efficacy in malignant pleural mesothelioma","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2024.214027_bb0445","article-title":"Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique","volume":"91","author":"Wang","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0450","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1672-2515(07)60054-2","article-title":"Effect of polyethyleneimine on the properties of concentrated suspensions of titanium dioxide microbeads","volume":"2","author":"Xu","year":"2004","journal-title":"China Particuology"},{"issue":"1","key":"10.1016\/j.bioadv.2024.214027_bb0455","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jcis.1998.5946","article-title":"Effect of block and graft copolymers on the stability of colloidal silica","volume":"210","author":"Bijsterbosch","year":"1999","journal-title":"J. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0460","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s13346-020-00802-8","article-title":"Afatinib-loaded inhalable PLGA nanoparticles for localizedtherapy of non-small cell lung cancer (NSCLC)\u2014development and in-vitroefficacy","volume":"11","author":"Elbatanony","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.bioadv.2024.214027_bb0465","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1208\/s12249-020-01724-x","article-title":"Cyclodextrin complexation for enhanced stability and non-invasive pulmonary delivery of resveratrol\u2014applications in non-small cell lung cancer treatment","volume":"21","author":"Wang","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2024.214027_bb0470","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.reactfunctpolym.2016.08.008","article-title":"Poly(lactide-co-glycolide)\/cyclodextrin (polyethyleneimine) microspheres for controlled delivery of dexamethasone","volume":"107","author":"Bucatariu","year":"2016","journal-title":"React. Funct. Polym."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0475","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"D","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"1","key":"10.1016\/j.bioadv.2024.214027_bb0480","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2018.1488497","article-title":"Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon","volume":"9","author":"Zakeri","year":"2018","journal-title":"Nano Rev. Exp."},{"issue":"2","key":"10.1016\/j.bioadv.2024.214027_bb0485","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/01932691.2018.1467773","article-title":"One-step synthesis of polyethylenimine-coated magnetic nanoparticles and its demulsification performance in surfactant-stabilized oil-in-water emulsion","volume":"40","author":"Zhao","year":"2019","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0490","unstructured":"Gardenhire DS, Nozart L, Hinski ST. Aerosol Delivery Devices for Respiratory Therapists."},{"issue":"3","key":"10.1016\/j.bioadv.2024.214027_bb0495","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/jamp.2009.0795","article-title":"Electrostatic charge characteristics of jet nebulized aerosols","volume":"23","author":"Kwok","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.bioadv.2024.214027_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118995","article-title":"Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: repurposing quinacrine for lung cancer therapeutics","volume":"577","author":"Vaidya","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.bioadv.2024.214027_bb0505","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1211\/jpp.61.12.0002","article-title":"Electrostatics of pharmaceutical inhalation aerosols","volume":"61","author":"Kwok","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioadv.2024.214027_bb0510","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mimet.2013.12.011","article-title":"Optimization of resazurin-based viability staining for quantification of microbial biofilms","volume":"98","author":"Van den Driessche","year":"2014","journal-title":"J. Microbiol. Methods"},{"issue":"9","key":"10.1016\/j.bioadv.2024.214027_bb0515","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/08853282211064098","article-title":"In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres","volume":"36","author":"Li","year":"2022","journal-title":"J. Biomater. Appl."},{"issue":"12","key":"10.1016\/j.bioadv.2024.214027_bb0520","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0142-9612(96)00199-8","article-title":"Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features","volume":"18","author":"Schierholz","year":"1997","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2024.214027_bb0525","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2024.214027_bb0530","unstructured":"MIC EUCAST [Internet]. [cited 2024 Jul 21]. Available from: https:\/\/mic.eucast.org\/search\/show-registration\/3223?back=https:\/\/mic.eucast.org\/search\/?search%255Bmethod%255D%3Dmic%26search%255Bantibiotic%255D%3D-1%26search%255Bspecies%255D%3D411%26search%255Bdisk_content%255D%3D-1%26search%255Blimit%255D%3D50."},{"issue":"4","key":"10.1016\/j.bioadv.2024.214027_bb0535","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3923\/ajaps.2016.178.184","article-title":"Effect of Polyethyleneimine stabilizer on size and morphology of gold nanoparticles","volume":"9","author":"Ibrahim","year":"2016","journal-title":"Asian J. Appl. Sci."},{"issue":"20","key":"10.1016\/j.bioadv.2024.214027_bb0540","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1039\/C7RA13597A","article-title":"Antimicrobial activity of nano-sized silver colloids stabilized by nitrogen-containing polymers: the key influence of the polymer capping","volume":"8","author":"S. Batista","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2024.214027_bb0545","unstructured":"Zeta Potential An Introduction in 30 Minutes. In [cited 2023 Aug 30]. Available from: https:\/\/www.semanticscholar.org\/paper\/Zeta-Potential-An-Introduction-in-30-Minutes\/ce38d81ee8d3f5f2a6bef221ed3e5e22b3f3378e."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082400270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277295082400270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:47:33Z","timestamp":1733132853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277295082400270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":109,"alternative-id":["S277295082400270X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.214027","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections \u2013 Development and in-vitro characterization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.214027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214027"}}